Instrument Inactif

Communiqués MorphoSys AG Hanseatische Wertpapierboerse Hamburg

Actions

MOR

DE0006632003

Communiqués

15/09/14	MorphoSys AG : Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs	GL
04/09/14	MorphoSys AG : to Present at Six Investor Conferences in September	GL
20/08/14	MorphoSys AG : to Host Conference Call on License Agreement with Emergent to Co-Develop and Commercialize Prostate Cancer Drug Candidate MOR209/ES414	GL
19/08/14	MorphoSys AG : and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414	GL
28/07/14	MorphoSys AG : Provides Update on the Company's Proprietary Drug Portfolio	GL
28/07/14	MorphoSys AG : Reports Results for the First Six Months of 2014	GL
23/07/14	MorphoSys AG : and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development	GL
21/07/14	MorphoSys AG : to Host Q2 2014 Conference Call on 28 July 2014	GL
18/07/14	MorphoSys AG : Receives Additional Patents on Novel Antibody Platform Ylanthia in the US and First Patent in China	GL
12/06/14	MorphoSys AG : and Merck Serono Enter Strategic Immuno-Oncology Collaboration	GL
02/06/14	MorphoSys AG : to Present at Four Investor Conferences in June	GL
23/05/14	MorphoSys AG : Annual General Meeting of MorphoSys AG Approves All Proposals of the Company's Management	GL
20/05/14	MorphoSys AG : MOR208 Program to Receive Orphan Drug Designation from FDA and EMA for the Treatment of CLL/SLL	GL
06/05/14	MorphoSys AG : to Present at Two Upcoming Investor Conferences	GL
29/04/14	MorphoSys AG : and Temple University Sign Therapeutic Antibody Discovery Partnership	GL
29/04/14	MorphoSys AG : Reports Results for the First Quarter of 2014	GL
23/04/14	MorphoSys AG : to Host Q1 2014 Conference Call on 29 April 2014	GL
11/04/14	MorphoSys AG : Announcement of the Convening of the AGM in Munich/Germany on 23 May 2014 according to sec. 121 para. 4a AktG with the objective of Europe-wide distribution	GL
31/03/14	MorphoSys AG : to Present at Two Upcoming Investor Conferences	GL
03/03/14	MorphoSys AG : to Present at Four Upcoming Investor Conferences	GL
03/03/14	MorphoSys AG : to Start Share Buy-Back Program	GL
28/02/14	MorphoSys AG : Reports Results for Fiscal Year 2013	GL
20/02/14	MorphoSys AG : Invitation to Year End 2013 Conference Call of MorphoSys AG on 28 February 2014	GL
17/02/14	MorphoSys AG : Announces Clinical Milestone in Anti-Inflammatory Program	GL
10/02/14	MorphoSys AG : to Present at Three Investor Conferences in February	GL